You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global (United States, European Union and China) Antacids Market Research Report 2019-2025

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they''re also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antacids Market Size Growth Rate by Type (2019-2025)
1.3.2 Proton Pump Inhibitor
1.3.3 H2 Antagonist
1.3.4 Acid Neutralizers
1.4 Market Segment by Application
1.4.1 Global Antacids Market Share by Application (2019-2025)
1.4.2 Rx Drug
1.4.3 OTC Drug
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Antacids Market Size
2.1.1 Global Antacids Revenue 2014-2025
2.1.2 Global Antacids Sales 2014-2025
2.2 Antacids Growth Rate by Regions
2.2.1 Global Antacids Sales by Regions 2014-2019
2.2.2 Global Antacids Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Antacids Sales by Manufacturers
3.1.1 Antacids Sales by Manufacturers 2014-2019
3.1.2 Antacids Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Antacids Revenue by Manufacturers (2014-2019)
3.2.2 Antacids Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antacids Market Concentration Ratio (CR5 and HHI)
3.3 Antacids Price by Manufacturers
3.4 Key Manufacturers Antacids Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antacids Market
3.6 Key Manufacturers Antacids Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Proton Pump Inhibitor Sales and Revenue (2014-2019)
4.1.2 H2 Antagonist Sales and Revenue (2014-2019)
4.1.3 Acid Neutralizers Sales and Revenue (2014-2019)
4.2 Global Antacids Sales Market Share by Type
4.3 Global Antacids Revenue Market Share by Type
4.4 Antacids Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Antacids Sales by Application

6 United States
6.1 United States Antacids Breakdown Data by Company
6.2 United States Antacids Breakdown Data by Type
6.3 United States Antacids Breakdown Data by Application

7 European Union
7.1 European Union Antacids Breakdown Data by Company
7.2 European Union Antacids Breakdown Data by Type
7.3 European Union Antacids Breakdown Data by Application

8 China
8.1 China Antacids Breakdown Data by Company
8.2 China Antacids Breakdown Data by Type
8.3 China Antacids Breakdown Data by Application

9 Rest of World
9.1 Rest of World Antacids Breakdown Data by Company
9.2 Rest of World Antacids Breakdown Data by Type
9.3 Rest of World Antacids Breakdown Data by Application
9.4 Rest of World Antacids Breakdown Data by Countries
9.4.1 Rest of World Antacids Sales by Countries
9.4.2 Rest of World Antacids Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antacids
10.1.4 Antacids Product Introduction
10.1.5 AstraZeneca Recent Development
10.2 Takeda Pharmaceutical
10.2.1 Takeda Pharmaceutical Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antacids
10.2.4 Antacids Product Introduction
10.2.5 Takeda Pharmaceutical Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antacids
10.3.4 Antacids Product Introduction
10.3.5 Pfizer Recent Development
10.4 Reckitt Benckiser
10.4.1 Reckitt Benckiser Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antacids
10.4.4 Antacids Product Introduction
10.4.5 Reckitt Benckiser Recent Development
10.5 Bayer
10.5.1 Bayer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antacids
10.5.4 Antacids Product Introduction
10.5.5 Bayer Recent Development
10.6 Procter?Gamble
10.6.1 Procter?Gamble Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Antacids
10.6.4 Antacids Product Introduction
10.6.5 Procter?Gamble Recent Development
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Antacids
10.7.4 Antacids Product Introduction
10.7.5 GlaxoSmithKline Recent Development
10.8 Johnson?Johnson
10.8.1 Johnson?Johnson Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Antacids
10.8.4 Antacids Product Introduction
10.8.5 Johnson?Johnson Recent Development
10.9 CONBA
10.9.1 CONBA Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Antacids
10.9.4 Antacids Product Introduction
10.9.5 CONBA Recent Development
10.10 Xiuzheng Pharma
10.10.1 Xiuzheng Pharma Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Antacids
10.10.4 Antacids Product Introduction
10.10.5 Xiuzheng Pharma Recent Development
10.11 Sanofi
10.12 Bausch Health
10.13 CR SANJIU
10.14 Reddy''s
  • FORMAT: PDF
  • PUBLISHED DATE: Aug, 2019
  • NO OF PAGES: 115